Read it here
The significant weight loss achieved with GLP-1 therapy varies by agent and dosewith semaglutide 2.4mg (Wegovy) achieving approximately 15% body weight reduction at 68 weeks, while liraglutide 3mg (Saxenda) typically produces 5-8% weight loss
To improve transparency, an adapted PRISMA-style flow diagram documenting identification, screening, eligibility assessment, de-duplication, and selection of the RCT evidence base and the proof-of-concept Bayesian subset is provided in the Supplementary Appendix Figure 1, together with details of the search strategy, screening process, and data extraction
Fiber & Fermented Foods Gut-friendly fibers and fermented foods increase GLP-1 activity by feeding beneficial bacteria and supporting blood sugar regulation
Seek prompt or emergency medical care as appropriate
Sundin's team will assess your full health profile to determine whether the program is appropriate for you